Thompson Alexis A. Insider Trades

Insider Trading History

Track insider trading activity for Thompson Alexis A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Global Blood Therapeutics
Global Blood Therapeutics GBT
Director
Holding Value $0 0 shares
Last Trade
Oct 05, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$247k 3,600 shares
$68.49
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Director
Holding Value $384k 5,600 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 5,600 shares
$22.30
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Director
Holding Value $227k 3,308 shares
Last Trade
Jun 14, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.2k 908 shares
$22.30
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Director
Holding Value $329k 4,800 shares
Last Trade
Mar 17, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$74.9k 2,400 shares
$31.19
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Director
Holding Value $96.7k 1,412 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86k 2,320 shares
$37.09
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Director
Holding Value $767k 11,200 shares
Last Trade
Mar 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$815k 18,400 shares
$44.28
$68.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up